112248 ⎘
Vectors comprising a targeting moiety; Vectors comprising as targeting moiety peptide derived from defined protein from viruses negative strand RNA viruses rhabdoviridae, e.g. VSV
RETROVIRAL TRANSDUCTION USING POLOXAMERS
#2TARGETED EXTRACELLULAR VESICLES COMPRISING MEMBRANE PROTEINS WITH ENGINEERED GLYCOSYLATION SITES
#3COMPOUNDS FOR IMPROVED VIRAL TRANSDUCTION
#4MODIFIED HEMATOPOIETIC STEM/PROGENITOR AND NON-T EFFECTOR CELLS, AND USES THEREOF
#5REPLICATION-COMPETENT VESICULAR STOMATITIS VIRUSES
#6Cancer immunotherapy by delivering class II MHC antigens using a VLP-replicon
#7RETROVIRAL TRANSDUCTION USING POLOXAMERS
#8FUSOSOME COMPOSITIONS FOR T CELL DELIVERY
#9LENTIVIRAL TRANSDUCTION METHODS
#10MODIFIED HEMATOPOIETIC STEM/PROGENITOR AND NON-T EFFECTOR CELLS, AND USES THEREOF
#11MULTICISTRONIC VECTOR FOR SURFACE ENGINEERING LENTIVIRAL PARTICLES
#12LDLR negative packaging cell line for the production of VSV-G pseudotyped retroviral vector particles or virus particles thereof
#13ONCOLYTIC RHABDOVIRUS
#14Compounds for improved viral transduction
#15Cancer immunotherapy by delivering class II MHC antigens using a VLP-replicon
#16IMPROVED LENTIVIRUSES FOR TRANSDUCTION OF HEMATOPOIETIC STEM CELLS
#17Use of Microvesicles in the Treatment of Medical Conditions
#18Immortalization of Splenic and Peripheral Blood Macrophages Using a Multi-Cistronic V-RAF/V-MYC Lentivirus
#19Retroviral transduction using poloxamers
#20Targeted extracellular vesicles comprising membrane proteins with engineered glycosylation sites
#21Replication-competent vesicular stomatitis viruses
#22DELIVERY OF PACKAGED RNA TO MAMMALIAN CELLS
#23Nucleic acid application primers
#24Compounds for improved viral transduction
#25Method for detecting protein-protein interactions in a cell utilizing particle-forming polypeptide-bait fusion proteins and virus-like particles
#26Use of microvesicles in the treatment of medical conditions
#27Transgenic VERO-CD4/CCR5 cell line
#28Method of preparing T cells with increased activity
#29Methods and compositions for protein delivery
#30Gene vector
#31ONCOLYTIC RHABDOVIRUS
#32Compounds for improved viral transduction
#33MODIFIED HEMATOPOIETIC STEM/PROGENITOR AND NON-T EFFECTOR CELLS, AND USES THEREOF
#34LENTIVIRAL VECTORS AND USES THEREOF
#35Recombinant Influenza Viruses for Vaccines and Gene Therapy
#36REPEATED ADMINISTRATION OF LENTIVIRAL VECTORS TO RESPIRATORY CELLS
#37Replication-competent vesicular stomatitis viruses
#38Modified stem cells and uses thereof
#39Identification of antibodies specific for lyssaviruses and methods of their use
#40COCAL ENVELOPE PSEUDOTYPED RETROVIRAL VECTOR PRODUCER CELLS
#41Cell Lines
#42Cocal vesiculovirus envelope pseudotyped retroviral vectors
#43Retroviral transduction using poloxamers
#44Transgenic Vero-CD4/CCR5 cell line
#45Replication-competent vesicular stomatitis viruses
#46Replication-competent VSV-HIV Env vaccines
#47Targeted extracellular vesicles comprising membrane proteins with engineered glycosylation sites
#48Virus like vesicles (VLVS) based vaccines to prevent or treat chronic hepatitis B virus (HBV) infection
#49Evolution of high-titer virus-like vesicles for vaccine applications
#50Delivery of packaged RNA to mammalian cells
#51Pseudotyped lentiviral vectors
#52Methods and compositions for protein delivery
#53Recombinant influenza viruses for vaccines and gene therapy
#54Identification of antibodies specific for at least two different lyssaviruses
#55Diagnostic and treatment for chronic and acute phase myeloid leukemia
#56Lentiviral vector based immunological compounds against malaria
#57Gene vector
#58Vector for the selective silencing of a gene in astrocytes
#59Trapping mammalian protein-protein complexes in virus-like particles utilizing HIV-1 GAG-bait fusion proteins
#60Replication-competent vesicular stomatitis viruses
#61Retroviral transduction using poloxamers
#62Delivery of packaged RNA to mammalian cells
#63Lentiviral gene transfer vectors and their medicinal applications
#64Compounds for improved viral transduction
#65Reassortant influenza viruses for vaccines
#66Oncolytic rhabdovirus
#67Neuron-specific retrograde transport vector
#68Use of microvesicles in the treatment of medical conditions
#69Lentiviral vector based immunological compounds against malaria
#70Baculoviruses with enhanced virion production and a method for the production of baculoviruses
#71Lentiviral gene transfer vectors and their medicinal applications
#72Retrograde transport viral vector system having envelope comprising fused glycoprotein
#73Diagnostic and treatment for chronic and acute phase myeloid leukemia
#74COCAL VESICULOVIRUS ENVELOPE PSEUDOTYPED RETROVIRAL VECTORS
#75Recombinant influenza viruses for vaccines and gene therapy
#76Vector utilizing borna disease virus and use thereof
#77Non-Integrating Retroviral Vector Vaccines
#78Different serotypes of vesicular stomatitis virus as expression vectors for immunization regimens
#79Biomolecule Surface Display and Uses Thereof
#80RECOMBINANT KOI HERPESVIRUS (KHV) OR CYPRINID HERPESVIRUS 3 (CYHV-3) AND A VACCINE FOR THE PREVENTION OF A DISEASE CAUSED BY KHV/CYHV-3 IN CYPRINUS CARPIO CARPIO OR CYPRINUS CARPIO KOI
#81Methods and compositions for protein delivery
#82RECOMBINANT INFLUENZA VIRUSES FOR VACCINES AND GENE THERAPY
#83MODULATION OF PRODUCTION OF RETROVIRUSES BY APOBEC4
#84Oncolytic rhabdovirus
#85VIRAL VACCINE VECTORS
#86Compositions and methods for monosynaptic transport
#87Lentiviral gene transfer vectors and their medicinal applications
#88RHABDOVIRIDAE VIRUS PREPARATIONS
#89TREATMENT OF PAIN THROUGH EXPRESSION OF OPIOID RECEPTORS
#90Lentiviral vectors allowing RNAi mediated inhibition of GFAP and vimentin expression
#91METHOD AND KIT FOR EFFICIENT REPROGRAMMING OF SOMATIC CELLS
#92REPEATED ADMINISTRATION OF LENTIVIRAL VECTORS TO RESPIRATORY CELLS
#93Methods of treating lysosomal storage related diseases by gene therapy
#94Gene vector
#95Production of Lentiviral Vectors
#96RECOMBINANT INFLUENZA VIRUSES FOR VACCINES AND GENE THERAPY
#97Therapeutic agents for diseases associated with apoptotic degeneration in ocular tissue cells that use SIV-PEDF vectors
#98Pseudotyped retroviral vectors and methods of use thereof
#99Method for transforming a hair follicle
#100Pseudotyped Baculovirus and its Use
#101Method and means for producing high titer, safe, recombinant lentivirus vectors
#102Compositions and methods for monosynaptic transport
#103Medicine for Treating Tumor and Use Therefor in Preparation of the Medicaments for Treating Tumor
#104Vector system
#105Viral Particles Containing An Alphavirus-Derived Vector And Method For Preparing Said Viral Particle
#106Non-integrative and non-replicative lentivirus, preparation and uses thereof
#107Lentivirus vectors for gene transfer to alveolar epithelial cells
#108Neurite regeneration
#109Method of treating arthritis using lentiviral vectors in gene therapy
#110Chimaeric vector system
#111ONCOLYTIC VIRUS
#112HIGH EFFICIENCY SIN VECTOR
#113Lentiviral apoe2 gene therapy
#114Paramyxovirus-derived RNP
#115Peptide-enhanced transfections
#116CAEV-based vector systems
#117Viral vectors with surface or envelope components
#118Process for preparing retrovirus vector for gene therapy
#119System producing infectious recombinant influenza virus
#120Transduction vector based on modified HIV-2
#121Vector for transfection of eukaryotic cells
#122Retinoic acid receptor beta-2, its agonists, and gene therapy vectors for the treatment of neurological disorders
#123Recombinant influenza viruses for vaccines and gene therapy
#124Methods of treating lysosomal storage related diseases by gene therapy
#125Methods and composition for visualizing and interfering with chromosomal tethering of extrachromosomal molecules
#126Retroviral vectors
#127Lentiviral vectors and uses thereof
#128Vector packaging cell line
#129Vaccination of skunks and/or mongooses against rabies
#130Method of preparing a treatment product, treatment product and a plasmid construct
#131Single cell analysis of HIV replication capacity and drug resistance
#132Pseudotyped viruses and methods for their use
#133Method of transducing ES cells
#134Recombinant influenza vectors with a polII promoter and ribozymes for vaccines and gene therapy
#135Pseudotyped lentiviral vectors and uses thereof